<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Comparison of performance of 3 serum-based Down syndrome screening tests according to prespecified detection rate, false-positive rate, and population</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Comparison of performance of 3 serum-based Down syndrome screening tests according to prespecified detection rate, false-positive rate, and population</h1>
<div class="graphic"><div class="figure"><div class="ttl">Comparison of performance of 3 serum-based Down syndrome screening tests according to prespecified detection rate, false-positive rate, and population</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="14%"></colgroup><colgroup width="1%"></colgroup><colgroup span="2" width="14%"></colgroup><colgroup width="1%"></colgroup><colgroup span="2" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1" colspan="2">Quadruple test<br/> (AFP, uE3, hCG, InhA at 15-20 weeks)</td> <td class="sublist1_other" rowspan="13"><span class="small"> </span></td> <td class="subtitle1" colspan="2">Combined test<br/> (NT, PAPP-A, hCG at 12 weeks)</td> <td class="sublist1_other" rowspan="13"><span class="small"> </span></td> <td class="subtitle1" colspan="2">Integrated test<br/> (NT and PAPP-A at 12 weeks plus AFP, uE3, hCG, InhA at 15-20 weeks)</td> </tr> <tr class="centered"> <td><strong>DR (%)</strong></td> <td> </td> <td><strong>FPR (%)</strong></td> <td> </td> <td><strong>FPR (%)</strong></td> <td> </td> <td><strong>FPR (%)</strong> </td> </tr> <tr class="centered"> <td>70</td> <td> </td> <td>2.0</td> <td> </td> <td>1.3</td> <td> </td> <td> 0.2</td> </tr> <tr class="centered"> <td>80</td> <td> </td> <td>4.5</td> <td> </td> <td>3.6</td> <td> </td> <td> 0.7</td> </tr> <tr class="divider_bottom centered"> <td>90</td> <td> </td> <td>11.7</td> <td> </td> <td>11.7</td> <td> </td> <td> 3.2</td> </tr> <tr class="centered"> <td><strong>FPR (%)</strong></td> <td><strong>DR (%)</strong></td> <td> </td> <td><strong>DR (%)</strong></td> <td> </td> <td><strong>DR (%)</strong></td> <td> </td> </tr> <tr class="centered"> <td>1</td> <td>62</td> <td> </td> <td>67</td> <td> </td> <td>83</td> <td> </td> </tr> <tr class="centered"> <td>3</td> <td>75</td> <td> </td> <td>78</td> <td> </td> <td>90</td> <td> </td> </tr> <tr class="divider_bottom centered"> <td>5</td> <td>81</td> <td> </td> <td>83</td> <td> </td> <td>93</td> <td> </td> </tr> <tr class="centered"> <td><strong>Risk cutoff (1:N)</strong></td> <td><strong>DR (%)</strong></td> <td><strong>FPR (%)</strong></td> <td><strong>DR (%)</strong></td> <td><strong>FPR (%)</strong></td> <td><strong>DR (%)</strong></td> <td><strong>FPR (%)</strong></td> </tr> <tr class="centered"> <td>1:100</td> <td>74</td> <td>2.5</td> <td>75</td> <td>1.9</td> <td>85</td> <td>1.3</td> </tr> <tr class="centered"> <td>1:200</td> <td>82</td> <td>4.7</td> <td>81</td> <td>3.8</td> <td>89</td> <td>2.4</td> </tr> <tr class="centered"> <td>1:300</td> <td>86</td> <td>6.6</td> <td>84</td> <td>5.5</td> <td>91</td> <td>3.4</td> </tr> </tbody></table></div><div class="graphic_lgnd">Because the combined test does not include AFP, screening for neural tube defects (if desired) needs to be performed separately. The quadruple test is the only one of these tests that does not require availability of ultrasound to measure nuchal translucency. All 3 tests will report an increased risk for trisomy 18, if present. All results assume the pregnancy is dated by ultrasound, serum markers are corrected for maternal weight, and total hCG is measured (if the free beta subunit measurement is used, the performance is expected to be slightly improved).</div><div class="graphic_footnotes">DR: detection rate; FPR: false-positive rate; AFP: alpha-fetoprotein; uE3: unconjugated estriol; inhA: inhibin A; PAPP-A: pregnancy associated plasma protein A; NT: nuchal translucency; hCG: human chorionic gonadotropin.</div><div class="graphic_reference">Data from: Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7:1.</div><div id="graphicVersion">Graphic 119540 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
